Chronic Kidney Disease and Nutrition by Sofia Acevedo, Danielle Aycart, Jeanette Andrade

“… Chronic kidney disease (CKD) is considered a public health issue within the United States because an estimated 37 million adults or 15% of the population have this disease. …”
Get full text

Chronic Kidney Disease and Nutrition by Sofia Acevedo, Danielle Aycart, Jeanette Andrade

“… Chronic kidney disease (CKD) is considered a public health issue within the United States because an estimated 37 million adults or 15% of the population have this disease. …”
Get full text

Creatinine- and Cystatin C-Based Incidence of Chronic Kidney Disease and Acute Kidney Disease in AKI Survivors by Claire Rimes-Stigare, Bo Ravn, Akil Awad, Klara Torlén, Claes-Roland Martling, Matteo Bottai, Johan Mårtensson, Max Bell

“…Chronic kidney disease (CKD) is defined as the estimated glomerular filtration rate (eGFR) less than 60 ml/min/1.73 m2 persisting for more than 90 days. …”
Get full text

Bisphenol A in Chronic Kidney Disease by Emilio González-Parra, Jose Antonio Herrero, Usama Elewa, Ricardo J. Bosch, Alberto Ortiz Arduán, Jesus Egido

Get full text

Developmental Programming of Hypertension and Kidney Disease by Euming Chong, Ihor V. Yosypiv

“…The risk of developing late-onset diseases such as hypertension, chronic kidney disease (CKD), obesity or type 2 diabetes is increased in infants born prematurely at <37 weeks of gestation or in low birth weight (LBW) infants weighing <2,500 g at birth. …”
Get full text

Roles of Inflammasomes in Inflammatory Kidney Diseases by Jinjin Fan, Kaifeng Xie, Liqin Wang, Nuoyan Zheng, Xueqing Yu

“…Inflammasomes are closely linked to many kidney diseases such as acute kidney injury and chronic kidney diseases. …”
Get full text

Chronic Kidney Disease in Disadvantaged Populations by David Martins, Lawrence Agodoa, Keith Norris

“…Disadvantaged populations across the globe exhibit a disproportionate burden of chronic kidney disease (CKD) because of differences in CKD occurrence and outcomes. …”
Get full text

Finerenone in the management of diabetes kidney disease by Parijat De, May T Khine, Andrew Frankel, Gabrielle Goldet, Debasish Banerjee, Rosa M Montero, Tahseen A Chowdhury, Damien Fogarty, Janaka Karalliedde, Ritwika Mallik, Dipesh C Patel, Mona Wahba, Peter Winocour, Sagen Zac-Varghese, Stephen Bain, Adnan Sharif, Srikanth Bellary, Indranil Dasgupta

Subjects: Get full text

Growth Retardation in Children with Kidney Disease by Paulina Salas, Viola Pinto, Josefina Rodriguez, Maria Jose Zambrano, Veronica Mericq

“…Growth failure is almost inextricably linked with chronic kidney disease (CKD) and end-stage renal disease (ESRD). …”
Get full text

MicroRNAs in Diabetic Kidney Disease by Rong Li, Arthur C. K. Chung, Xueqing Yu, Hui Y. Lan

“…Rapid growth of diabetes and diabetic kidney disease exerts a great burden on society. Owing to the lack of effective treatments for diabetic kidney disease, treatment relies on drugs that either reduces its progression or involve renal replacement therapies, such as dialysis and kidney transplantation. …”
Get full text

Phosphorus and Nutrition in Chronic Kidney Disease by Emilio González-Parra, Carolina Gracia-Iguacel, Jesús Egido, Alberto Ortiz

“…In chronic renal disease, a low dietary protein content slows the progression of kidney disease, especially in patients with proteinuria and decreases the supply of phosphorus, which has been directly related with progression of kidney disease and with patient survival. …”
Get full text

Characterization of diabetic kidney disease in 235 patients: clinical and pathological insights with or without concurrent non-diabetic kidney disease by Mengjie Jiang, Hongyu Chen, Jing Luo, Jinhan Chen, Li Gao, Qin Zhu

Subjects: Get full text

Chronic Kidney Disease: Potassium and Your Diet by Ashley R. Kendall, Nancy J. Gal, Wendy J. Dahl

“…FSHN16-9/FS287: Chronic Kidney Disease: Potassium and Your Diet (ufl.edu) …”
Get full text

Research Progress on the Role of Inflammasomes in Kidney Disease by Kun Chi, Xiaodong Geng, Chao Liu, GuangYan Cai, Quan Hong

“…Inflammasomes are closely related to kidney diseases. In particular, the NLRP3 (NACHT, LRR, and PYD domain-containing protein 3) inflammasome has been shown to cause acute and chronic kidney diseases by regulating canonical and noncanonical mechanisms of inflammation. …”
Get full text

Chronic Kidney Disease: Phosphorus and Your Diet by Nancy J. Gal, Lauren Headrick, Kate Bennett, Wendy J. Dahl

“…FSHN15-10/FS273: Chronic Kidney Disease: Phosphorus and Your Diet (ufl.edu) …”
Get full text

Erratum to “Growth Retardation in Children with Kidney Disease” by Paulina Salas, Viola Pinto, Josefina Rodriguez, Maria Jose Zambrano, Veronica Mericq

Get full text

Resistant Hypertension in Nondialysis Chronic Kidney Disease by Silvio Borrelli, Luca De Nicola, Giovanna Stanzione, Giuseppe Conte, Roberto Minutolo

“…Resistant hypertension (RH) is defined as blood pressure (BP) that remains above the target of less than 140/90 mmHg in the general population and 130/80 mmHg in people with diabetes mellitus or chronic kidney disease (CKD) in spite of the use of at least three full-dose antihypertensive drugs including a diuretic or as BP that reaches the target by means of four or more drugs. …”
Get full text

Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets by Stephanie Toth-Manikowski, Mohamed G. Atta

“…Diabetes is a worldwide epidemic that has led to a rise in diabetic kidney disease (DKD). Over the past two decades, there has been significant clarification of the various pathways implicated in the pathogenesis of DKD. …”
Get full text

Prognostic and Diagnostic Value of Endocan in Kidney Diseases by Elisabeth Samouilidou, Virginia Athanasiadou, Eirini Grapsa

“…In this review, we summarize the current evidence concerning the role of endocan in kidney diseases, with emphasis on its prognostic and diagnostic value. …”
Get full text

Antioxidants in Kidney Diseases: The Impact of Bardoxolone Methyl by Jorge Rojas-Rivera, Alberto Ortiz, Jesus Egido

“…Drugs targeting the renin-angiotensin-aldosterone system (RAAS) are the mainstay of therapy to retard the progression of proteinuric chronic kidney disease (CKD) such as diabetic nephropathy. However, diabetic nephropathy is still the first cause of end-stage renal disease. …”
Get full text